Trials / Completed
CompletedNCT05487703
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
Tofacitinib Use in Rituximab-Experienced RA Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 318 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to characterize the use of tofacitinib after use of rituximab in patients with Rheumatoid Arthritis in a real-world setting.
Conditions
Timeline
- Start date
- 2022-11-14
- Primary completion
- 2022-12-23
- Completion
- 2022-12-23
- First posted
- 2022-08-04
- Last updated
- 2024-10-08
- Results posted
- 2024-10-08
Locations
1 site across 1 country: Morocco
Source: ClinicalTrials.gov record NCT05487703. Inclusion in this directory is not an endorsement.